Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Karlowsky

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
The Journal of Antimicrobial Chemotherapy|July 27, 2014
Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatientsG V Sanchez, A M G Baird, J A Karlowsky, et al.
Antimicrobial Agents and Chemotherapy|February 27, 1999
Synergy of an investigational glycopeptide, LY333328, with once-daily gentamicin against vancomycin-resistant Enterococcus faecium in a multiple-dose, in vitro pharmacodynamic modelS A Zelenitsky, B Booker, N Laing, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1994
The accumulation of fluoroquinolones in Staphylococcus aureus during the postantibiotic effectR J Davidson, G R Drobot, J A Karlowsky, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 25, 2004
Rates of antimicrobial resistance among common bacterial pathogens causing respiratory, blood, urine, and skin and soft tissue infections in pediatric patientsM E Jones, J A Karlowsky, D C Draghi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 20, 2003
In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000-2001M E Jones, R S Blosser-Middleton, I A Critchley, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2011
In vitro activity of ceftazidime combined with NXL104 versus Pseudomonas aeruginosa isolates obtained from patients in Canadian hospitals (CANWARD 2009 study)A Walkty, M DeCorby, P R S Lagacé-Wiens, et al.
The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses|February 21, 2012
The new fluoroquinolones: A critical reviewG G Zhanel, A Walkty, L Vercaigne, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2013
In vitro activity of ceftolozane-tazobactam against Pseudomonas aeruginosa isolates obtained from patients in Canadian hospitals in the CANWARD study, 2007 to 2012A Walkty, J A Karlowsky, H Adam, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1997
In vitro antifungal activity of BMS-181184 against systemic isolates of Candida, Cryptococcus, and Blastomyces speciesJ A Karlowsky, G G Zhanel, T V Balko, et al.
Antimicrobial Agents and Chemotherapy|February 4, 1998
Comparison of CO2 generation (BACTEC) and viable-count methods to determine the postantibiotic effect of antimycobacterial agents against Mycobacterium avium complexG G Zhanel, M H Saunders, J N Wolfe, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
The Journal of Antimicrobial Chemotherapy|July 27, 2014
Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatientsG V Sanchez, A M G Baird, J A Karlowsky, et al.
Antimicrobial Agents and Chemotherapy|February 27, 1999
Synergy of an investigational glycopeptide, LY333328, with once-daily gentamicin against vancomycin-resistant Enterococcus faecium in a multiple-dose, in vitro pharmacodynamic modelS A Zelenitsky, B Booker, N Laing, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1994
The accumulation of fluoroquinolones in Staphylococcus aureus during the postantibiotic effectR J Davidson, G R Drobot, J A Karlowsky, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 25, 2004
Rates of antimicrobial resistance among common bacterial pathogens causing respiratory, blood, urine, and skin and soft tissue infections in pediatric patientsM E Jones, J A Karlowsky, D C Draghi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 20, 2003
In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000-2001M E Jones, R S Blosser-Middleton, I A Critchley, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2011
In vitro activity of ceftazidime combined with NXL104 versus Pseudomonas aeruginosa isolates obtained from patients in Canadian hospitals (CANWARD 2009 study)A Walkty, M DeCorby, P R S Lagacé-Wiens, et al.
The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses|February 21, 2012
The new fluoroquinolones: A critical reviewG G Zhanel, A Walkty, L Vercaigne, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2013
In vitro activity of ceftolozane-tazobactam against Pseudomonas aeruginosa isolates obtained from patients in Canadian hospitals in the CANWARD study, 2007 to 2012A Walkty, J A Karlowsky, H Adam, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1997
In vitro antifungal activity of BMS-181184 against systemic isolates of Candida, Cryptococcus, and Blastomyces speciesJ A Karlowsky, G G Zhanel, T V Balko, et al.
Antimicrobial Agents and Chemotherapy|February 4, 1998
Comparison of CO2 generation (BACTEC) and viable-count methods to determine the postantibiotic effect of antimycobacterial agents against Mycobacterium avium complexG G Zhanel, M H Saunders, J N Wolfe, et al.
Pageof 8